Johnson & Johnson Cuts Drug Prices to Secure Tariff Exemptions in Trump Deal

Johnson & Johnson Cuts Drug Prices to Secure Tariff Exemptions in Trump Deal

By Cygnus | 09 Jan 2026

Johnson & Johnson agrees to cut U.S. drug prices in exchange for tariff relief from the Trump administration and plans new factories in North Carolina and Pennsylvania.

Sun Pharma Advanced Research to Cut Workforce by 40% in Cost Optimisation Push

Sun Pharma Advanced Research to Cut Workforce by 40% in Cost Optimisation Push

By Axel Miller | 08 Jan 2026

SPARC slashes 40% of workforce and consolidates labs to save $10M annually. Discover how the Sezaby PRV ruling could clear the firm’s $46M debt.

The $280 Ozempic: How a Canadian Bridge to India is Slashing U.S. Weight-Loss Costs

The $280 Ozempic: How a Canadian Bridge to India is Slashing U.S. Weight-Loss Costs

By Axel Miller | 07 Jan 2026

U.S. patients are bypassing $1,100 retail prices with $280 India-sourced Ozempic pens via Canada. A deep dive into the 2026 semaglutide supply chain.

US slaps sanctions on 6 Indian companies over imports from Iran

US slaps sanctions on 6 Indian companies over imports from Iran

By Unnikrishnan | 03 Aug 2025

The United States on Wednesday imposed sanctions on six Indian companies, including Alchemical Solutions, Global Industrial Chemicals, Jupiter Dye Chem, Ramniklal S Gosalia & Co

Glenmark Pharma Hits Record High on Landmark AbbVie Licensing Deal

Glenmark Pharma Hits Record High on Landmark AbbVie Licensing Deal

By Cygnus | 11 Jul 2025

Glenmark Pharmaceuticals shares rallied 10% on Friday to reach a record high after its biotech subsidiary signed a significant licensing agreement with U.S. drugmaker AbbVie.

Sanofi to acquire Blueprint Medicines in $9.5 billion deal to bolster immunology push

Sanofi to acquire Blueprint Medicines in $9.5 billion deal to bolster immunology push

By Cygnus | 02 Jun 2025

French pharmaceutical giant Sanofi is set to acquire U.S.-based Blueprint Medicines Corporation in a deal worth up to $9.5 billion

AstraZeneca acquires EsoBiotec in $1 bn deal

AstraZeneca acquires EsoBiotec in $1 bn deal

18 Mar 2025

British-Swedish multinational pharmaceutical and biotechnology company AstraZenica on Monday announced the acquisition of biotechnology company EsoBiotech in a $1 billion transaction

Sun Pharma to acquire oncology therapy company Checkpoint in US

Sun Pharma to acquire oncology therapy company Checkpoint in US

11 Mar 2025

Sun Pharmaceutical Industries Ltd has entered into an agreement to acquire US-based immunotherapy and targeted oncology company, Checkpoint Therapeutics Inc

CSIR develops antibiotic for drug-resistant bacteria, indigenous formula for Paracetamol

CSIR develops antibiotic for drug-resistant bacteria, indigenous formula for Paracetamol

08 Jan 2025

Council of Scientific and Industrial Research (CSIR) has reported important breakthroughs, which include development of an anti-biotic to fight drug-resistant bacteria

Govt sets goal higher for India’s nutraceutical industry

Govt sets goal higher for India’s nutraceutical industry

08 Nov 2024

India is set to play a major role in the global nutraceutical industry, with its wealth of traditional knowledge, its Ayurveda system and policy support, as per government projections.

Stay ahead with Informachine News Trackers! Follow your selected sources, track business news with relevant keywords, and organize seamlessly using labels and bookmarks.

Get the business updates you need, fast, focused, and tailored just for you. Save time, stay informed, and never miss a beat!

Start your free subscription today!

Latest articles on Pharmaceuticals from Informachine

Downloaded on 08 Jan 2026

View details about the software product Informachine News Trackers